Efficacy and safety of trichloroacetate chemocauterization for pyriform sinus fistula
Not Applicable
- Conditions
- pyrifirm sinus fistula
- Registration Number
- JPRN-UMIN000020351
- Lead Sponsor
- Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with severe renal or liver dysfunction, with a risk for general anesthesia, or whom a doctor considered not eligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method duration of recurrence-free observation
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie trichloroacetate chemocauterization in pyriform sinus fistula treatment?
How does trichloroacetate chemocauterization compare to surgical excision for pyriform sinus fistula in terms of efficacy and safety?
Are there specific biomarkers that predict response to trichloroacetate chemocauterization in pyriform sinus fistula patients?
What are the potential adverse events and management strategies for trichloroacetate chemocauterization in pyriform sinus fistula?
What alternative chemocauterization agents are being explored for pyriform sinus fistula compared to trichloroacetate in clinical trials?